CVX vs XBIO · P/E 17, rev $118.66B vs rev $1.5M
Chevron Corp (CVX) versus Xenetic Biosciences Inc (XBIO) — a side-by-side from cached financials, not a winner call.
Chevron Corp (CVX) is a oil & gas integrated company listed on US. It is led by Michael K. Wirth.
Xenetic Biosciences Inc (XBIO) is a biotechnology company listed on US.
Latest reported CVX revenue for 2026-06-30 was $118.66B. Net income was $14.28B. CVX currently screens at market cap $250.20B and trailing P/E 16.5.
Latest reported XBIO revenue for 2026-06-30 was $1.5M. Net income was -$1.4M. Revenue was up 81.9% from 2026-03-31 to 2026-06-30. XBIO currently screens at market cap $5.7M.
CVX currently screens at market cap $250.20B and trailing P/E 16.5. XBIO currently screens at market cap $5.7M.
Not investment advice. Open the CVX and XBIO stock pages for the full models.
Not investment advice.